{"id":"W4404639336","doi":"10.51731/cjht.2024.1031","title":"Pembrolizumab (Keytruda)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Pembrolizumab; Reimbursement; Medicine; Gemcitabine; Drug; Vial; Audit; Family medicine; Chemotherapy; Medical physics; Internal medicine; Business; Pharmacology; Accounting; Cancer; Political science; Health care; Immunotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004812234,0.0002314228,0.0003287093,0.0007353012,0.0002431295,0.0007505689,0.0002955697,0.0003775087,0.008291857],"category_scores_gemma":[0.0008545483,0.00008124382,0.0003733786,0.0006044466,0.0001575173,0.0005337961,0.000297464,0.0008018204,0.002131666],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001082072,"about_ca_system_score_gemma":0.001005389,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006006425,"about_ca_topic_score_gemma":0.01833029,"domain_scores_codex":[0.999783,0.00004058056,0.00002332505,0.0000347689,0.00008756453,0.00003077432],"domain_scores_gemma":[0.9998066,0.00004297477,0.00005208897,0.000008611552,0.00006358326,0.00002622267],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005076572,0.00006113189,0.000465117,0.003383219,0.0001110657,0.0001609516,0.00002877116,0.0001320093,0.003612228,0.001680765,0.03703007,0.9528269],"study_design_scores_gemma":[0.0004568041,0.0005442636,0.00377951,0.002659432,0.0003029841,0.001382846,0.00003956509,0.0001024173,0.004462184,0.0006597755,0.9855958,0.00001442582],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.01077267,0.9284695,0.001332963,0.004375668,0.0008919049,0.0002481293,0.001682367,0.0001952741,0.05203143],"genre_scores_gemma":[0.1693891,0.7711262,0.00532934,0.005182678,0.0005269303,0.0002981708,0.002547968,0.00003711442,0.04556249],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.008291857,"threshold_uncertainty_score":0.02773905,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0493223292658819,"score_gpt":0.3740354626978171,"score_spread":0.3247131334319352,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}